# A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study

> **NCT01062269** · PHASE4 · COMPLETED · sponsor: **Louisville Metabolic and Atherosclerosis Research Center** · enrollment: 42 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cholestyramine
- **DRUG:** Cholestyramine
- **DRUG:** Tang

## Key facts

- **NCT ID:** NCT01062269
- **Lead sponsor:** Louisville Metabolic and Atherosclerosis Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-02
- **Final completion:** 2010-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2011-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01062269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01062269, "A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT01062269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*